Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Blockade for the Prevention of Atrial Fibrillation After Cardiac Surgery
NCT05357690Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Atrial fibrillation (AFib) comparing Stellate ganglion block with local anesthetic with Stellate ganglion block with saline placebo (2 arms). Primary endpoint: Incidence of atrial fibrillation at 1 week. Started Apr 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05357690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05357690.